Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor

Augenlicht, 1989 Gatta, 1998, Survival of colorectal cancer patients in Europe during the period 1978–1989, Eur J Cancer, 34, 2176, 10.1016/S0959-8049(98)00327-X Thiis-Evensen, 1999, Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63–72 years, Gut, 45, 834, 10.1136/gut.45.6.834 Zhang, 2002, Early diagnosis for colorectal cancer in China, World J Gastroenterol, 8, 21, 10.3748/wjg.v8.i1.21 Li, 2003, Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study, Chin Med J, 116, 200 Repetto, 2003, Geriatric oncology: A clinical approach to the older patient with cancer, Eur J Cancer, 39, 870, 10.1016/S0959-8049(03)00062-5 Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I Fearon, 1990, Identification of a chromosome 18q gene that is altered in colorectal cancers, Science, 247, 49, 10.1126/science.2294591 Kinzler, 1991, Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers, Science, 251, 1366, 10.1126/science.1848370 Harris, 1993, Clinical implications of the p53 tumor-suppressor gene, N Engl J Med, 329, 1318, 10.1056/NEJM199310283291807 Luo, 1995, Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon, Cancer Lett, 91, 235, 10.1016/0304-3835(95)03744-H Shim, 1998, Increased serum levels of mutant p53 proteins in patients with colorectal cancer, J Korean Med Sci, 13, 44, 10.3346/jkms.1998.13.1.44 Sandler, 1999, The role of blood vessels of soluble 53kDa protein and CEA in monitoring colon cancer patients, Anticancer Res, 19, 4229 Attallah, 2003, Detection of serum p53 protein in patients with different gastrointestinal cancers, Cancer Det Prev, 27, 127, 10.1016/S0361-090X(03)00024-2 Zusman, 1996, Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detection, Hum Antibodies Hybridomas, 7, 123, 10.3233/HAB-1996-7305 Zusman, 1998, Gel fiberglass membranes for affinity chromatography columns and their application to cancer detection, J Chromatogr B Biomed Sci Appl, 715, 297, 10.1016/S0378-4347(98)00022-X Gold, 1965, Demonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques, J Exp Med, 121, 439, 10.1084/jem.121.3.439 Paxton, 1987, Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family, Proc Natl Acad Sci USA, 84, 920, 10.1073/pnas.84.4.920 Benchimol, 1989, Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule, Cell, 57, 327, 10.1016/0092-8674(89)90970-7 Kouri, 1992, Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma, J Surg Oncol, 49, 78, 10.1002/jso.2930490204 Zhao, 1998, A clinical evaluation of serological diagnosis for pancreatic cancer, World J Gastroenterol, 4, 147, 10.3748/wjg.v4.i2.147 Marrelli, 1999, Prognostic significance of CEA, CA19-9 and CA72-4 preoperative serum levels in gastric carcinoma, Oncology, 57, 55, 10.1159/000012001 Ohuchi, 1989, Comparison of serum assays for TAG-72, CA19-9, and CEA in gastrointestinal carcinoma patients, Jpn J Clin Oncol, 19, 242 Schlessinger, 1992, Growth-factor signaling by receptor tyrosine kinase, Neuron, 9, 383, 10.1016/0896-6273(92)90177-F Rajkumar, 2001, Growth factors and growth factor receptors in cancer (Review), Curr Sci, 81, 535 Yamazaki, 1998, Inhibition of tumor growth by ribozyme mediated suppression of aberrant epidermal growth factor receptor gene expression, J Natl Cancer Inst, 90, 581, 10.1093/jnci/90.8.581 Luo, 1994, Detection of serum p53 protein in lung cancer patients, J Occup Med, 36, 155, 10.1097/00043764-199402000-00010 Partanen, 1995, Serum oncoproteins in asbestosis patients, Clin Chem, 41, 1844, 10.1093/clinchem/41.12.1844 Osaki, 1995, Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma, Chest, 108, 157, 10.1378/chest.108.1.157 Choi, 1997, Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients, Cancer, 79, 1879, 10.1002/(SICI)1097-0142(19970515)79:10<1879::AID-CNCR6>3.0.CO;2-B Oh, 2000, Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma, Clin Cancer Res, 6, 4760 Fucini, 1987, Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, CA19-9 analysis and second look surgery, Dis Colon Rectum, 30, 273, 10.1007/BF02556172 Guadagni, 1995, CA72-4 serum marker-a new tool in the management of carcinoma patients, Cancer Invest, 13, 227, 10.3109/07357909509011692 ASCO, 1998, Update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7,1997, by the American Society of Clinical Oncology, J Clin Oncol, 16, 793, 10.1200/JCO.1998.16.2.793 EGTM, 1999, Tumor markers in the gastrointestinal cancers–EGTM recommendations. European Group on the Tumor Markers, Anticancer Res, 2811 Carpelan-Holmström, 2004, Estimating the probability of cancer with several tumor markers in patients with colorectal cancer, Oncology, 66, 296, 10.1159/000078330 Marchena, 2003, Use of the preoperative levels of CEA in patients with colorectal cancer, Hepatogastroenterology, 50, 1017 Duffy, 2003, Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines, Eur J Cancer., 39, 718, 10.1016/S0959-8049(02)00811-0 Tabuchi, 1999, Immunohistochemical p53 protein expression in advanced colorectal cancer lesions: no association with prognostic variables or survival, Bull Health Sci Kobe, 15, 27 Sugo, 1999, The significance of p53 mutation as an indicator of the biological behavior of recurrent hepatocellular carcinomas, Surg Today, 29, 849, 10.1007/BF02482774 Bazan, 2002, DNA ploidy S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study, J Cancer Res Clin Oncol, 128, 650, 10.1007/s00432-002-0394-6 Tang, 2001, Humoral response to p53 in human colorectal tumors: a prospective study of 1 209 patients, Int J Cancer, 94, 859, 10.1002/ijc.1541 Lechpammer, 2004, Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy, Int J Colorectal Dis, 19, 114, 10.1007/s00384-003-0553-5 Takeda, 2001, Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection, Int J Clin Oncol, 6, 45, 10.1007/PL00012079 Forslund, 2001, Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas, Int J Oncol, 19, 501 Broll, 2001, p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue, Int J Colorectal Dis, 16, 22, 10.1007/s003840000263 Hildebrandt, 1997, Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency, Exp Hematol, 25, 57 Khazaie, 1993, EGF receptor in neoplasia and metastasis, Cancer Metastasis Rev, 12, 255, 10.1007/BF00665957 Baselga, 1994, The epidermal growth factor receptor as a target for therapy in breast carcinoma, Breast Cancer Res Treat, 29, 127, 10.1007/BF00666188 Witters, 1999, Antisense oligonucleotides to the epidermal growth factor receptor, Breast Cancer Res Treat, 53, 41, 10.1023/A:1006127527107 Naruse, 2002, Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug resistant cell line in vitro and in vivo, Int J Cancer, 98, 310, 10.1002/ijc.10173 Bradley, 1986, Increased expression of the epidermal growth factor receptor on human colon carcinoma cells, Arch Surg, 121, 1242, 10.1001/archsurg.121.11.1242 Ozawa, 1988, Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach, Jpn J Cancer Res, 79, 1201, 10.1111/j.1349-7006.1988.tb01545.x Giacomelli, 2003, Persistence of epidermal growth factor receptor and interleukin 10 in blood of colorectal cancer patients after surgery identifies patients with high risk to relapse, Clin Cancer Res, 9, 2678 Kopp, 2003, Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels, Dis Colon Rectum, 46, 1391, 10.1007/s10350-004-6756-1 Layfield, 2003, Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma, J Surg Oncol, 83, 227, 10.1002/jso.10272 Amador, 2004, Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer, Clin Colorectal Cancer, 4, 51, 10.3816/CCC.2004.n.010 DiCarlo, 2001, Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias, Oncol Rep, 8, 387 Langlois, 1997, Expression of growth factor receptors is not a prognostic indicator in young patients with colorectal cancer, J R Coll Surg Edinb, 42, 98 Lim, 1996, p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma, Int J Cancer, 69, 200, 10.1002/(SICI)1097-0215(19960621)69:3<200::AID-IJC9>3.0.CO;2-3 Allegra, 2003, Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’B and C colon cancer: A national cancer institute–national surgical adjuvant breast and bowel project collaborative study, J Clin Oncol, 21, 241, 10.1200/JCO.2003.05.044 Paluszkiewicz, 2004, p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumors, Cancer Detect Prev, 28, 252, 10.1016/j.cdp.2004.05.001 Adrover, 1999, Expression of high p53 levels in colorectal cancer: a favorable prognostic factor, Br J Cancer, 81, 122, 10.1038/sj.bjc.6690660 Nicholson, 2001, EGFR and cancer prognosis, Eur J Cancer, 37, S9, 10.1016/S0959-8049(01)00231-3